Application of Mass Multivariate Analysis on Neuroimaging Data Sets for Precision Diagnostics of Depression
We used the Mass Multivariate Method on structural, resting-state, and task-related fMRI data from two groups of patients with schizophrenia and depression in order to define several regions of significant relevance to the differential diagnosis of those conditions. The regions included the left planum polare (PP), the left opercular part of the inferior frontal gyrus (OpIFG), the medial orbital gyrus (MOrG), the posterior insula (PIns), and the parahippocampal gyrus (PHG). This study delivered evidence that a multimodal neuroimaging approach can potentially enhance the validity of psychiatric diagnoses. Structural, resting-state, or task-related functional MRI modalities cannot provide independent biomarkers. Further studies need to consider and implement a model of incremental validity combining clinical measures with different neuroimaging modalities to discriminate depressive disorders from schizophrenia. Biological signatures of disease on the level of neuroimaging are more likely to underpin broader nosological entities in psychiatry.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
---|---|
Enthalten in: |
Diagnostics (Basel, Switzerland) - 12(2022), 2 vom: 12. Feb. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Paunova, Rositsa [VerfasserIn] |
---|
Links: |
---|
Themen: |
Depression |
---|
Anmerkungen: |
Date Revised 01.03.2022 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/diagnostics12020469 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM337361118 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM337361118 | ||
003 | DE-627 | ||
005 | 20231225234234.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/diagnostics12020469 |2 doi | |
028 | 5 | 2 | |a pubmed24n1124.xml |
035 | |a (DE-627)NLM337361118 | ||
035 | |a (NLM)35204560 | ||
035 | |a (PII)469 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Paunova, Rositsa |e verfasserin |4 aut | |
245 | 1 | 0 | |a Application of Mass Multivariate Analysis on Neuroimaging Data Sets for Precision Diagnostics of Depression |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 01.03.2022 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a We used the Mass Multivariate Method on structural, resting-state, and task-related fMRI data from two groups of patients with schizophrenia and depression in order to define several regions of significant relevance to the differential diagnosis of those conditions. The regions included the left planum polare (PP), the left opercular part of the inferior frontal gyrus (OpIFG), the medial orbital gyrus (MOrG), the posterior insula (PIns), and the parahippocampal gyrus (PHG). This study delivered evidence that a multimodal neuroimaging approach can potentially enhance the validity of psychiatric diagnoses. Structural, resting-state, or task-related functional MRI modalities cannot provide independent biomarkers. Further studies need to consider and implement a model of incremental validity combining clinical measures with different neuroimaging modalities to discriminate depressive disorders from schizophrenia. Biological signatures of disease on the level of neuroimaging are more likely to underpin broader nosological entities in psychiatry | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a depression | |
650 | 4 | |a mass multivariate analysis | |
650 | 4 | |a neuroimaging | |
650 | 4 | |a schizophrenia | |
700 | 1 | |a Kandilarova, Sevdalina |e verfasserin |4 aut | |
700 | 1 | |a Todeva-Radneva, Anna |e verfasserin |4 aut | |
700 | 1 | |a Latypova, Adeliya |e verfasserin |4 aut | |
700 | 1 | |a Kherif, Ferath |e verfasserin |4 aut | |
700 | 1 | |a Stoyanov, Drozdstoy |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Diagnostics (Basel, Switzerland) |d 2011 |g 12(2022), 2 vom: 12. Feb. |w (DE-627)NLM250111136 |x 2075-4418 |7 nnns |
773 | 1 | 8 | |g volume:12 |g year:2022 |g number:2 |g day:12 |g month:02 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/diagnostics12020469 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 12 |j 2022 |e 2 |b 12 |c 02 |